8
panel
FasterCures Private Dinner (Invite only)
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
article
Does it Work for Patients? A Multi-Step Approach to Defining Performance and Measuring Progress Across the Biomedical Ecosystem
Quick Links
Step One: Discover Existing Research »
Step Two: Articulate Ideals»
Step Three: Ident
ify Measures »
+ Read More
article
Patient Organizations as Research and Data Partners
What data assets are patient organizations creating, and how are they adding value to the work of pa
rtners trying to accelerate therapeutic development for patients?
+ Read More
article
Pediatric Biomarkers: A Slow Zone for Patients
Q. When it comes to oncology, what is one specific example of how the system is not performing well
for patients, in other words, a Slow Zone?
+ Read More